Photo
Corps éditorial
Elisabeth Baudin est statisticienne. Elle a commencé sa carrière dans l’industrie pharmaceutique et a rejoint Epicentre il y a 15 ans. Elle travaille principalement sur les essais cliniques thérapeutiques et vaccinaux.
Oral Regimens for Rifampin-Resistant, Fluoroquinolone-Susceptible Tuberculosis.
Référence de l'article:
The New England journal of medicine 2025 Jan 30; 392(5); . doi: 10.1056/NEJMoa2400327. Epub 2025 01 29
Bedaquiline, delamanid, linezolid, and clofazimine for rifampicin-resistant and fluoroquinolone-resistant tuberculosis (endTB-Q): an open-label, multicentre, stratified, non-inferiority, randomised, controlled, phase 3 trial.
Référence de l'article:
The Lancet. Respiratory medicine 2025 Jul 16; . doi: 10.1016/S2213-2600(25)00194-8. Epub 2025 07 16
Effect of mass campaigns with full and fractional doses of pneumococcal conjugate vaccine (Pneumosil) on the reduction of nasopharyngeal pneumococcal carriage in Niger: a three-arm, open-label, cluster-randomised trial.
Référence de l'article:
The Lancet. Infectious diseases 2025 Jan 08; . doi: 10.1016/S1473-3099(24)00719-9. Epub 2025 01 08
Evaluating newly approved drugs in combination regimens for multidrug-resistant tuberculosis with fluoroquinolone resistance (endTB-Q): study protocol for a multi-country randomized controlled trial.
Référence de l'article:
Trials 2023 Nov 30; 24(1); . doi: 10.1186/s13063-023-07701-6. Epub 2023 11 30
High severity of abortion complications in fragile and conflict-affected settings: a cross-sectional study in two referral hospitals in sub-Saharan Africa (AMoCo study).
Référence de l'article:
BMC pregnancy and childbirth 2023 Mar 04; 23(1); . doi: 10.1186/s12884-023-05427-6. Epub 2023 03 04
Evaluating newly approved drugs in combination regimens for multidrug-resistant tuberculosis with fluoroquinolone resistance (endTB-Q): study protocol for a multi-country randomized controlled trial.
Référence de l'article:
Trials 2023 Nov 30; 24(1); . doi: 10.1186/s13063-023-07701-6. Epub 2023 11 30
The duration of chemoprophylaxis against malaria after treatment with artesunate-amodiaquine and artemether-lumefantrine and the effects of pfmdr1 86Y and pfcrt 76T: a meta-analysis of individual patient data.
Référence de l'article:
BMC medicine 2020 Feb 25; 18(1); 47. doi: 10.1186/s12916-020-1494-3. Epub 2020 02 25
Effect of high-dose rifampicin on efavirenz pharmacokinetics: drug-drug interaction randomized trial.
Référence de l'article:
The Journal of antimicrobial chemotherapy 2020 Jan 30; doi: 10.1093/jac/dkz557. Epub 2020 01 30